Chinook Therapeutics KDNY
$ 40.39
0.0%
Quarterly report 2023-Q2
added 08-07-2023
Country |
USA |
IPO year |
2015 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Mr. Stephen Isaacs |
Employees in the company |
96 |
Shares |
64.4 M |
Market Cap[1] |
$ 2.6 B |
EBITDA (LTM) |
$ -224 M |
P/E (LTM) |
-12.49 |
P/S (LTM) |
451.32 |
EPS (LTM) |
-3.23 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.